A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics.
Mov Disord. 2008 Oct 19. [Epub ahead of print]
PMID:
18932271 [PubMed - as supplied by publisher]